On International Clinical Trials Day, we’re proud to publish the Bellberry Clinical Trial Activity Report for 2022. This annual publication represents over one third of the Australia wide CTN trial activity across the development lifecycle.
This report demonstrates capability and capacity in a broad range of research areas. It also captures the originating funding location for inward investment in Sponsored clinical trials, again demonstrating Australia’s active participation in the global development process.
In this reporting period Bellberry was also delighted to have been awarded full re-accreditation for five years by the global Association for the Accreditation of Human Research Protection Programs (AAHRPP). Bellberry is the only organisation to achieve AAHRPP accreditation reflecting Bellberry’s commitment to protecting the rights and welfare of research participants.
If you have any questions relating to this data, please contact us at bellberry@bellberry.com.au
Click here to register and download the Bellberry Clinical Trial Activity Report 2022